0001947723-22-000001.txt : 20221013 0001947723-22-000001.hdr.sgml : 20221013 20221013160622 ACCESSION NUMBER: 0001947723-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221013 DATE AS OF CHANGE: 20221013 EFFECTIVENESS DATE: 20221013 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Curavit Clinical Research Corp CENTRAL INDEX KEY: 0001947723 IRS NUMBER: 844218254 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-461679 FILM NUMBER: 221309174 BUSINESS ADDRESS: STREET 1: 18 LARCH LANE CITY: SCARSDALE STATE: NY ZIP: 10583 BUSINESS PHONE: 917-885-0024 MAIL ADDRESS: STREET 1: 18 LARCH LANE CITY: SCARSDALE STATE: NY ZIP: 10583 D 1 primary_doc.xml X0708 D LIVE 0001947723 Curavit Clinical Research Corp 18 LARCH LANE SCARSDALE NY NEW YORK 10583 917-885-0024 DELAWARE None None Corporation true 2019 Joel Morse c/o Curavit Clinical Research Corp 18 Larch Lane Scarsdale NY NEW YORK 10583 Executive Officer Director David Hanaman c/o Curavit Clinical Research Corp 18 Larch Lane Scarsdale NY NEW YORK 10583 Director Nathanael Lentz c/o Curavit Clinical Research Corp 18 Larch Lane Scarsdale NY NEW YORK 10583 Director Rich Lester c/o Curavit Clinical Research Corp 18 Larch Lane Scarsdale NY NEW YORK 10583 Director Other Health Care Decline to Disclose 06b false 2022-09-28 false true true true false 0 8893329 8493329 400000 false 26 0 0 0 false Curavit Clinical Research Corp /s/ Joel Morse Joel Morse Chief Executive Officer 2022-10-13